Multidisciplinary Research Teams Target Blindness and Stroke Damage Using Regenerative Medicine

Tissue Engineering Pioneer Michael Sefton to Lead Medicine by Design as Executive Director

Renée Brost and Bryan San Luis Win Staff IMPACT Awards

Director Brenda Andrews Named University Professor

U of T Research Paves Way for an Off-the-Shelf Supply of Cells for Immunotherapy

Recent publications

Engineering the haemogenic niche mitigates endogenous inhibitory signals and controls pluripotent stem cell-derived blood emergence. Nat Comms 2017 May 25.

Progenitor T-cell differentiation from hematopoietic stem cells using Delta-like-4 and VCAM-1. Nat Methods 2017 Apr 10.

Multilayered Control of Alternative Splicing Regulatory Networks by Transcription Factors. Mol Cell 2017 Feb 2.

A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. Mol Cell 2017 Jan 5.

Driving Innovation in Medicine

Discoveries made in basic science are the foundation for all future progress in medicine. Emerging genomic and stem cell technologies hold the promise of personalized treatments that are tailored to patient’s unique genetic makeup and physiology. Through our collaborative approach, the Donnelly Centre is in a position to make breakthrough discoveries in biology and to lead the world in advancing personalized medicine.

Your gift to the Donnelly Centre allows researchers to explore new and innovative ideas that will transform our understanding of biology. It supports discovery that will unearth the cause of human disease, advance diagnosis and disease detection, create personalized therapies, and reverse injury through regenerative medicine.

View our 2016 Annual Report to learn about our recent accomplishments

Back to Top